Latest News
Members of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center joined more than 11,000 physicians, scientists, and trainees focused on advancing research and clinical care in breast cancer attending the annual San Antonio Breast Cancer Symposium December 10-14, 2024. The Symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease to an international audience of academic and private physicians and researchers.
- December 06, 2024
Thazin Nwe Aung, PhD, Associate Research Scientist in Pathology, has been selected for a Patterson Mentored Research Award. Dr. Aung is a member of the Rimm Lab, and her mentor is David Rimm, MD, PhD, Anthony N. Brady Professor of Pathology and of Medicine (Medical Oncology).
- November 12, 2024Source: HemOnc Today
Researchers developed a highly sensitive, analytic, quantitative immunofluorescence assay that may enable more patients with lung cancer to benefit from an approved targeted therapy.The test measures HER2, a commonly used biomarker for breast cancer.
- September 26, 2024
A new, highly sensitive test for a cancer biomarker could allow more lung cancer patients to benefit from a recently FDA-approved chemotherapy.
- July 09, 2024
Two genes could serve as a screening mechanism for resistance to immunotherapy in non-small cell lung cancer (NSCLC), though further research is needed.
- June 26, 2024
A recent study conducted by scientists at Yale Cancer Center demonstrates that spatial gene signatures can significantly enhance the prediction of immunotherapy outcomes in patients with melanoma.
- June 26, 2024Source: OncLive
David Rimm, MD, PhD, Anthony N. Brady Professor of Pathology, professor, medicine, Medical Oncology, Yale School of Medicine; director, Physician Scientist Training Program, Pathology Research, director, Tissue Microarray Facility, director, Yale Pathology Tissue Services, Pathology, Yale Cancer Center, discusses the primary challenges in distinguishing between HER2-low and HER2-ultralow breast cancer using current immunohistochemistry diagnostic kits.
- May 01, 2024
Several faculty members in the Department of Pathology at Yale School of Medicine have been recognized as among the Top Doctors in Connecticut.
- April 12, 2024
The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.
- March 20, 2024
Declines in the death rate for breast cancer have furthered overall progress in cancer mortality.